Stock listing

OTC:NEXI NexImmune, Inc. Stock

Home listing (OTC) of NexImmune, Inc.

Follow NexImmune, Inc. into a list and get an email when it puts out news.

Share price · OTC:NEXI

$0.0001 USD 0.0000 (0.0%)

Close on Oct 30, 2026

Past year 0.0% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
$0.0001 – $0.0001 USDOct 30, 2026
Market cap
$139 USDAt the close on Oct 30, 2026 · price × 1.39M shares outstanding
52-week range
$0.0001 – $0.0003 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
$0 USDMedian day 0 shares · 60 days with no trades · last 3 months, Jul 30, 2026 – Oct 30, 2026
NexImmune, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
OTC:NEXI · Home$0.0001 USD0.0000 (0.0%)—$0.0001$0.0001$0.0001$0.0001Close on Oct 30, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · OTC:NEXI · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00011,365
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001100
$0.00010.00000.0%$0.0001$0.0001$0.0001550
$0.00010.00000.0%$0.0002$0.0002$0.0001100
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001171
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001178
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001132
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010

Splits

1 split · OTC:NEXI · every price before a split is adjusted for it

DayRatioWhat
1-for-25Consolidation
Ticker
OTC:NEXI
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

NexImmune, Inc. on 6ix

Sector
Health care
Industry
Biotechnology

Where NexImmune, Inc. is listed

ListingExchangeCountryCurrency
OTC:NEXI · Home listing · This pageOTCUnited StatesUSD
Lang & Schwarz:A3EUTVLang & SchwarzGermanyEUR
LS Exchange:A3EUTVLS ExchangeGermanyEUR

Valuation

price Oct 30, 2026

Enterprise value
No statements on 6ix yet
P/E
No statements on 6ix yet
EV/sales
No statements on 6ix yet
EV/EBITDA
No statements on 6ix yet
Price/book
No statements on 6ix yet
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
0.31

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
NexImmune, Inc. · OTC:NEXIUS$139n/an/an/an/an/an/an/a0.31
Chimeric Therapeutics Limited · ASX:CHMUS$292,816−US$220,193n/a−0.1×n/a0.2×−262.8%2.5×n/a
CERo Therapeutics Holdings, Inc. · OTC:CEROUS$265,035−US$190,890n/an/an/an/an/an/a1.47
CDT Equity Inc. · NASDAQ:CDTUS$234,109−US$1.49Mn/an/an/a0.0×n/a0.0×1.14
GlucoTrack, Inc. · NASDAQ:GCTKUS$217,049−US$887,951n/an/an/an/an/an/a1.73
Regen BioPharma, Inc. · OTC:RGBPUS$167,528US$167,289n/a0.7×n/an/a−501.4%n/a1.20
CNBX Pharmaceuticals Inc. · OTC:CNBXUS$160,577US$151,090n/an/an/an/an/an/a1.78
Fifty 1 Labs Inc. · OTC:FITYUS$118,532US$282,021n/a6,000×n/an/an/an/a-1.17
GB Sciences, Inc. · OTC:GBLXUS$81,414US$2.07Mn/an/an/an/an/an/a-0.46
Lyra Therapeutics, Inc. · OTC:LYRAUS$53,246US$14.42Mn/a36.2×n/an/an/an/a0.67
ZyVersa Therapeutics, Inc. · OTC:ZVSAUS$810US$1.20Bn/an/an/an/an/an/a-0.56
Median of the othersUS$164,053US$159,19018.5×0.1×−382.1%1.3×1.14

Events

QuarterResults
Q2 2024Aug 7, 2024 · After close
Q1 2024Apr 16, 2024 · After close
Q4 2023Feb 7, 2024 · Before open
Q3 2023Nov 17, 2023 · After close
Q2 2023Aug 10, 2023 · After close
Q1 2023May 15, 2023 · After close
Q4 2022Mar 28, 2023 · After close
Q3 2022Nov 14, 2022 · After close
Q2 2022Aug 15, 2022 · After close
Q1 2022May 12, 2022 · After close
All 15 quarters
QuarterResults
Q4 2021Mar 9, 2022 · After close
Q3 2021Nov 12, 2021 · Before open
Q2 2021Aug 9, 2021 · After close
Q1 2021May 17, 2021 · After close
Q4 2020Feb 11, 2021 · After close

Open Events

Financials

Annual, in USD

Income statement

LineFY2023FY2022FY2021FY2020FY2019FY2018
Revenue000000
Cost of revenue1.02M1.50M870.3K619.0K436.4K204.6K
Gross profit-1.02M-1.50M-870.3K-619.0K-436.4K-204.6K
Research and development18.3M47.1M37.5M17.8M15.2M8.00M
Selling, general and administrative13.0B15.9M15.8M10.0M5.71M5.24M
Operating income-29.2M-63.1M-53.3M-27.9M-20.9M-13.2M
Depreciation and amortization1.02M994.8K870.3K619.0K436.4K204.6K
EBITDA-28.2M-62.1M-52.4M-27.2M-20.4M-13.0M
Interest expense576.7M905.3K1.68M7.26K0
Income before tax-32.3M-62.5M-50.9M-29.9M-20.5M-12.8M
Income tax-2-576.7M843.9K1.77M-246.8K409.2K
Net income-32.3M514.2M-51.7M-31.6M-20.3M-12.8M
Earnings per share, basic-30.82534.29-56.67-34.76-22.53-14.25

Balance sheet

LineFY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents3.20M34.6M30.3M5.03M9.13M426.0K
Short-term investments1.44M051.5M1.01B1.01M11.6M
Receivables74.5K6.42K73.6K
Inventory-19.5K61.1K
Current assets5.40M37.4M86.3M8.39M11.0M12.3M
Property, plant and equipment5.43M4.43M2.89M2.58M1.70M
Total assets8.59M43.1M91.0M11.3M13.7M14.1M
Accounts payable1.34M2.38M1.05M2.76M1.17M860.7K
Current liabilities5.08M10.3M7.22M27.0M3.03M3.00M
Total debt68.8K1.02M19.1M53.6M35.0M
Total liabilities5.08M10.8M7.27M27.1M3.11M3.33M
Shareholders' equity3.51M32.3M83.8M-15.8M10.6M10.8M
Shares outstanding1.05M962.4K913.2K910.3K900.9K900.9K

Cash flow

LineFY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-31.4M-51.2M-45.8M-26.4M-19.4M-11.1M
Capital spending-48.7K-1.26M-2.35M-864.7K-1.25M-937.8K
Free cash flow-31.5M-52.4M-48.1M-27.3M-20.7M-12.1M
Cash from investing-44.5K50.3M-53.8M221.9K9.42M-12.6M
Cash from financing05.18M124.9M22.1M18.8M9.18M
Dividends paid-377.6K
Change in cash-31.5M4.30M25.3M-4.10M8.77M-14.6M

Open Financials

Cap table

Built by 6ix from NexImmune, Inc.’s releases

Common shares
1,394,671
Fully diluted
1,394,671

Fully diluted

LineShares
Common shares1,394,671

Share count over time

CountShares
Nov 22, 20261,394,671

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Sol J. Barer
Other companies: Teva Pharmaceutical Industries Limited (Chairman of the Board Independent Director · Since at least Jan 1, 2018); Avalo Therapeutics, Inc. (Director · Feb 3, 2020 – Jun 15, 2021 · Past); PDS Biotechnology Corporation (Director · Sep 30, 2015 – Mar 15, 2019 · Past); CervoMed Inc. (Director · Nov 1, 2013 – Jul 24, 2014 · Past); Aevi Genomic Medicine LLC (Director · Jun 30, 2012 – Feb 3, 2020 · Past); InspireMD Inc. (Director · Jul 11, 2011 – Dec 7, 2016 · Past); Aegerion Pharmaceuticals Inc (Director · May 1, 2011 – Nov 29, 2016 · Past); Amicus Therapeutics Inc (Director · Jan 6, 2009 – Jun 9, 2016 · Past); Celgene Corporation (Director · Dec 31, 2005 – Jan 13, 2011 · Past)
Director · Feb 11, 2021 – Jul 5, 2023 · Past
Jerome Zeldis
Other companies: NexGel, Inc (Director · Since at least Mar 8, 2021); PTC Therapeutics, Inc. (Director · Since at least Jun 19, 2013); Soligenix, Inc. (Board Director · Since at least Jun 22, 2011); MetaStat Inc (Director · Oct 11, 2017 – Oct 11, 2017 · Past); Beyond Air, Inc. (Director · Mar 14, 2017 – Mar 14, 2017 · Past); Sorrento Therapeutics, Inc. (See Remarks · Aug 12, 2016 – Nov 26, 2018 · Past); Streamex Corp. (Director · Jul 20, 2015 – Jul 14, 2020 · Past)
Executive VP of Research & Dev · Feb 11, 2021 – Apr 5, 2022 · Past
Timothy Bertram
Other companies: ProKidney Corp. (Chief Executive Officer, Director · Jul 11, 2022 – Jan 16, 2023 · Past); Tengion Inc (Pres Rsrch & Dev, & Chf Sc Ofc · Apr 9, 2010 – Mar 4, 2013 · Past)
Director · Feb 11, 2021 – Jul 5, 2023 · Past
Alan S Roemer
Other companies: IN8bio, Inc. (Director · Since at least Jul 29, 2021)
Director · Feb 11, 2021 – Nov 21, 2023 · Past
John TrainerChief Financial Officer · Feb 11, 2021 – Apr 4, 2023 · Past
Kristi JonesPresident and CEO, Director · Feb 11, 2021 – Jun 11, 2024 · Past
Leena GandhiDirector · May 5, 2022 – Jul 5, 2023 · Past
Mathias OelkeChief Science Officer · Apr 5, 2022 – Apr 4, 2023 · Past
Paul D'AngioDirector · Feb 11, 2021 – Jul 5, 2023 · Past
Scott CarmerPresident and CEO, Director · Feb 11, 2021 – Feb 17, 2021 · Past
All 11 people
PersonSeat
Timothy StoverVP, Corporate Controller · Aug 30, 2023 – Aug 30, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about NexImmune, Inc.